Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.44 +0.01 (+3.00%)
As of: Oct 21, 2026 · 11:40 AM EDT

Reviva Pharmaceuticals Holdings (RVPH) Revenue (2019 - 2020)

Updated

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Revenue (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 16.99 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 15.03 Bn
10 Reviva Pharmaceuticals Holdings 5.72 Mn -63.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2020 3,800.00
Aug 31, 2020 9,892.00
May 31, 2020 109,175.00
Feb 29, 2020 1.20 Mn
Nov 30, 2019 323,704.00
Aug 31, 2019 351,738.00
May 31, 2019 398,746.00
Feb 28, 2019 -344,689.00
API Access

Reviva Pharmaceuticals Holdings Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RVPH&period=max&api_key=YOUR_API_KEY